How a Drug for Opioid and Alcohol Addiction Is Helping Treat Long COVID

The Epoch Times
26 March 2022
https://www.theepochtimes.com/how-a-drug-for-opioid-and-alcohol-addiction-is-helping-treat-long-covid_4363132.html

A drug that’s helping millions of people with opioid or alcohol dependence is also being used to treat those suffering symptoms of long COVID.

Newer Drugs for Rheumatoid Arthritis All Have Similar Risks — Maybe It’s Time to Go Natural?

Verve Times
15 March 2022
https://vervetimes.com/newer-drugs-for-rheumatoid-arthritis-all-have-similar-risks-maybe-its-time-to-go-natural/

Dr Sajad Zalzala, LDN Radio Show February 2022 (LDN, low dose naltrexone)

LDN in Clinical Practice - Andrew McCall, MB, ChB, DFM (2021 Conference) (LDN, low dose naltrexone)

The Use of LDN for Ophthalmic Conditions - Sebastian Denison, Pharm (2021 Conference) (LDN, low dose naltrexone)

This talk is about how they utilize LDN, their LDN protocol, and their outcomes and expectations. The information presented about humans can apply to animals as well.

Treating Children’s Health in a Special Needs Pediatric Practice - Brian Udell, MD (2021 Conference) (LDN, low dose naltrexone)

Lyme Disease - Darin Ingels, ND (2021 Conference) (LDN, low dose naltrexone)

Henoch-Schonlein Purpura - Sally Daughtrey, ND (2021 Conference) (LDN, low dose naltrexone)

In her presentation, Dr. Daughtry explains Henoch-Schonlein (HSP), its triggers and complications (such as serious hidden infections often missed initially), and the use of Low Dose Naltrexone in treating HSP. Dr. Daughtry gives an in-depth look into one pediatric case she treated successfully with LDN.